Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Comorbidities in Patients with Lichen Planopilaris: A Retrospective Case-control Study.

Manatis-Lornell A, Okhovat JP, Marks DH, Hagigeorges D, Senna MM.

J Am Acad Dermatol. 2019 Jul 12. pii: S0190-9622(19)32375-8. doi: 10.1016/j.jaad.2019.07.018. [Epub ahead of print] No abstract available.

PMID:
31306727
2.

Utility of laboratory testing in patients with female pattern hair loss.

Okhovat JP, Marks DH, Manatis-Lornell A, Hagigeorges D, Senna MM.

J Am Acad Dermatol. 2019 Jul 12. pii: S0190-9622(19)32372-2. doi: 10.1016/j.jaad.2019.07.015. [Epub ahead of print] No abstract available.

PMID:
31306723
3.

Successful Use of Dupilumab for Recalcitrant Atopic Dermatitis in an HIV Patient.

Marks DH, Piantadosi AL, Patil SU, Raff A, Yu J.

Dermatitis. 2019 Jul/Aug;30(4):276-277. doi: 10.1097/DER.0000000000000501. No abstract available.

PMID:
31261222
4.

Association of cicatricial alopecia with chemical hair straightening.

Marks DH, Hagigeorges D, Okhovat JP, Manatis-Lornell AJ, McMichael AJ, Senna MM.

Br J Dermatol. 2019 Jun 17. doi: 10.1111/bjd.18217. [Epub ahead of print]

PMID:
31206604
5.

Association Between Alopecia Areata, Anxiety, and Depression: A Systematic Review and Meta-analysis.

Okhovat JP, Marks DH, Manatis-Lornell A, Hagigeorges D, Locascio JJ, Senna MM.

J Am Acad Dermatol. 2019 Jun 1. pii: S0190-9622(19)30890-4. doi: 10.1016/j.jaad.2019.05.086. [Epub ahead of print]

PMID:
31163237
6.

Hair loss among transgender and gender-nonbinary patients: a cross-sectional study.

Marks DH, Hagigeorges D, Manatis-Lornell AJ, Dommasch E, Senna MM.

Br J Dermatol. 2019 May 3. doi: 10.1111/bjd.18099. [Epub ahead of print]

PMID:
31049935
7.

Gender-related cost discrepancies in a cohort of 110 facial moisturizers.

Manatis-Lornell AJ, Marks DH, Hagigeorges D, Okhovat JP, Senna MM.

J Cosmet Dermatol. 2019 Apr 15. doi: 10.1111/jocd.12954. [Epub ahead of print]

PMID:
30985070
8.

Hair Reduction for Transgender Persons: What Dermatologists Should Know and How They Can Help.

Marks DH, Peebles JK, Dommasch E.

JAMA Dermatol. 2019 Apr 3. doi: 10.1001/jamadermatol.2019.0149. [Epub ahead of print] No abstract available.

PMID:
30942820
9.

The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.

Marks DH, Okhovat JP, Hagigeorges D, Manatis-Lornell AJ, Isakoff SJ, Lacouture ME, Senna MM.

Breast Cancer Res Treat. 2019 Jun;175(2):267-276. doi: 10.1007/s10549-019-05169-0. Epub 2019 Feb 26. Review.

PMID:
30806923
10.

Dermatologic Surgical Care for Transgender Individuals.

Marks DH, Awosika O, Rengifo-Pardo M, Ehrlich A.

Dermatol Surg. 2019 Mar;45(3):446-457. doi: 10.1097/DSS.0000000000001718. Review.

PMID:
30789503
11.

The Therapeutic Potential of Cannabinoids in Dermatology

Marks DH, Friedman A.

Skin Therapy Lett. 2018 Nov;23(6):1-5.

12.

The Medical and Psychosocial Associations of Alopecia: Recognizing Hair Loss as More Than a Cosmetic Concern.

Marks DH, Penzi LR, Ibler E, Manatis-Lornell A, Hagigeorges D, Yasuda M, Drake LA, Senna MM.

Am J Clin Dermatol. 2019 Apr;20(2):195-200. doi: 10.1007/s40257-018-0405-2.

PMID:
30390206
13.

Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic Review.

Marks DH, Qureshi A, Friedman A.

JAMA Dermatol. 2018 Dec 1;154(12):1465-1472. doi: 10.1001/jamadermatol.2018.3465.

PMID:
30383138
14.

Reply to: "Risk of skin cancer in HIV-infected patients: a Danish nationwide cohort study".

Mansh MD, Marks DH.

J Am Acad Dermatol. 2018 Sep 14. pii: S0190-9622(18)32503-9. doi: 10.1016/j.jaad.2018.07.067. [Epub ahead of print] No abstract available.

PMID:
30222985
15.

Whole chromosome loss and associated breakage-fusion-bridge cycles transform mouse tetraploid cells.

Thomas R, Marks DH, Chin Y, Benezra R.

EMBO J. 2018 Jan 17;37(2):201-218. doi: 10.15252/embj.201797630. Epub 2017 Dec 1.

16.

Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit.

Marks DH, Thomas R, Chin Y, Shah R, Khoo C, Benezra R.

Cell Rep. 2017 May 30;19(9):1832-1845. doi: 10.1016/j.celrep.2017.05.021.

17.

Drug-induced liver disease: primer for the primary care physician.

O'Donnell JT, Marks DH, Danese P, O'Donnell JJ 3rd.

Dis Mon. 2014 Feb;60(2):55-104. doi: 10.1016/j.disamonth.2013.11.002. Review. No abstract available.

PMID:
24507900
18.

Drug utilization, safety and clinical use of Actos and Avandia.

Marks DH.

Int J Risk Saf Med. 2013 Jan 1;25(1):39-51. doi: 10.3233/JRS-120581. Review.

PMID:
23442297
19.

Biodegradation of polyester polyurethane by endophytic fungi.

Russell JR, Huang J, Anand P, Kucera K, Sandoval AG, Dantzler KW, Hickman D, Jee J, Kimovec FM, Koppstein D, Marks DH, Mittermiller PA, Núñez SJ, Santiago M, Townes MA, Vishnevetsky M, Williams NE, Vargas MP, Boulanger LA, Bascom-Slack C, Strobel SA.

Appl Environ Microbiol. 2011 Sep;77(17):6076-84. doi: 10.1128/AEM.00521-11. Epub 2011 Jul 15.

20.

Neurological complications of vaccination with outer surface protein A (OspA).

Marks DH.

Int J Risk Saf Med. 2011;23(2):89-96. doi: 10.3233/JRS-2011-0527.

PMID:
21673416
21.

Cardiomyopathy due to ingestion of Adderall.

Marks DH.

Am J Ther. 2008 May-Jun;15(3):287-9. doi: 10.1097/MJT.0b013e3180ed6291.

PMID:
18496266
22.
23.

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.

Kanesa-thasan N, Smucny JJ, Hoke CH, Marks DH, Konishi E, Kurane I, Tang DB, Vaughn DW, Mason PW, Shope RE.

Vaccine. 2000 Oct 15;19(4-5):483-91.

PMID:
11027812
24.

Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine.

Keller D, Koster FT, Marks DH, Hosbach P, Erdile LF, Mays JP.

JAMA. 1994 Jun 8;271(22):1764-8.

PMID:
8196120
25.

Effect of polymyxin B on hemoglobin-mediated hepatotoxicity.

Marks DH, Cooper T, Makovec T, Okerberg C, Lollini LO.

Mil Med. 1989 Apr;154(4):180-4.

PMID:
2543934
26.

Efficacy of antibacterial membrane and effect on blood components.

Marks DH, Medina F, Hou KC, Lee S, Blackmon A, Smith DJ.

Mil Med. 1988 Jul;153(7):337-40. No abstract available.

PMID:
3137493
27.

Deleterious effects of stroma-free hemoglobin used as resuscitative fluid for rats with ischemic intestinal shock.

Dawidson I, Drukker S, Hedlund B, Marks DH, Reisch J.

Crit Care Med. 1988 Jun;16(6):606-9.

PMID:
3371025
28.

Ascorbate-2-phosphate in red cell preservation. Clinical trials and active components.

Moore GL, Marks DH, Carmen RA, Ledford ME, Nelson EJ, Fishman RJ, Leng BS.

Transfusion. 1988 May-Jun;28(3):221-5.

PMID:
3130692
29.

Optimization and synthesis of pyridoxalated polymerized stroma-free hemoglobin solution.

Marks DH, Moore GL, Medina F, Boswell G, Zieske LR, Bolin RB, Zegna AI.

Mil Med. 1988 Jan;153(1):44-9. No abstract available.

PMID:
3126426
30.

Removal of bacteria from blood by charcoal hemoperfusion.

Marks DH, Medina F, Lee S, Blackmon A, Schuschereba ST.

Biomater Artif Cells Artif Organs. 1988;16(1-3):135-40.

PMID:
3052639
31.

Antibody response to transfusion with pyridoxalated polymerized hemoglobin solution.

Marks DH, Brown DR, Ottinger WE, Atassi MZ.

Mil Med. 1987 Sep;152(9):473-7. No abstract available.

PMID:
3118250
32.

Pyridoxalated polymerized stroma-free hemoglobin solution (SFHS-PP) as an oxygen-carrying fluid replacement for hemorrhagic shock in dogs.

Marks DH, Lynett JE, Letscher RM, TenEyck RP, Schaerle AD, Makovec GT, Medina F.

Mil Med. 1987 May;152(5):265-71. No abstract available.

PMID:
3108723
33.

Removal of bacteria from blood.

Marks DH, Hou KC, Medina F, Bolin RB.

Mil Med. 1987 Mar;152(3):156-60. No abstract available.

PMID:
3104832
35.

Pelvic hematoma after intercourse while on chronic anticoagulation.

Marks DH, Dellinger RP, Orrison WW.

Ann Emerg Med. 1984 Jul;13(7):554-6.

PMID:
6742562
36.

Stroma-free methemoglobin solution as an antidote for cyanide poisoning: a preliminary study.

Ten Eyck RP, Schaerdel AD, Lynett JE, Marks DH, Patrissi GA, Ottinger WE, Stansell MJ.

J Toxicol Clin Toxicol. 1983-1984;21(3):343-58.

PMID:
6676476
37.

Chemotactic attraction of Lumbricus terrestris coelomocytes to foreign tissue.

Marks DH, Stein EA, Cooper EL.

Dev Comp Immunol. 1979 Spring;3(2):277-85. No abstract available.

PMID:
478076
38.

Electron-microscopic observations of normal coelomocytes from the earthworm, Lumbricus terrestris.

Linthicum DS, Stein EA, Marks DH, Cooper EL.

Cell Tissue Res. 1977 Dec 19;185(3):315-30.

PMID:
202389
39.

Graft rejection in earthworms: an electron microscopic study.

Linthicum DS, Marks DH, Stein EA, Cooper EL.

Eur J Immunol. 1977 Dec;7(12):871-6.

PMID:
344047
40.

Aeromonas hydrophila in the coelomic cavity of the earthworms Lumbricus terrestris and Eisenia foetida.

Marks DH, Cooper EL.

J Invertebr Pathol. 1977 May;29(3):382-3. No abstract available.

PMID:
858944
41.

Earthworm coelomocytes in vitro.

Toupin J, Marks DH, Cooper EL, Lamoureux G.

In Vitro. 1977 Apr;13(4):218-22.

PMID:
873560

Supplemental Content

Loading ...
Support Center